Researchers from Yale University found that about 32 percent of new drug approvals between 2001 and 2010 were misappropriated. As safety problems became apparent following their approval by the FDA, all of the drugs in this category had to receive new warning labels after the fact, highlighting major flaws with the “gold standard” drug approval process. Read more here.